Sodium Bicarbonate 5gr (325mg)
NDC Package 45861-080-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Sodium Bicarbonate 5gr (325mg) is a . Marketed by Pharmaceutica North America, Inc., this product is identified by NDC 45861-080 and is authorized under FDA application M001.

Identification & Billing

NDC Package Code
45861-080-10
Package Description
1000 TABLET in 1 BOTTLE
Product Code
45861-080
11-Digit Billing Format
45861008010
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1000 EA

Clinical Specifications

Proprietary Name
Sodium Bicarbonate 5gr (325mg)
Dosage Form
-

Regulatory & Marketing

Labeler Name
Pharmaceutica North America, Inc.
FDA Application #
M001
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-01-2025
End Marketing Date
12-31-2025
Listing Expiration
12-31-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45861-080-10 identifies a specific commercial package of 1000 tablet in 1 bottle of Sodium Bicarbonate 5gr (325mg), labeled by Pharmaceutica North America, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pharmaceutica North America, Inc. on February 01, 2025. The current certification is valid through December 31, 2025.

How is this Pharmaceutica North America, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45861008010. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1000 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
45861-080-10
11-Digit CMS (5-4-2)
45861-0080-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.